Goodwin Procter advised Asher Biotherapeutics on the deal. Asher Biotherapeutics announced the closing of its Series B financing, which raised $108 million. The financing was led by...
Goodwin Procter advised Asher Biotherapeutics on the deal. Asher Biotherapeutics announced the closing of its Series B financing, which raised $108 million. The financing was led by...
You must be a Standard 1 Year member to access this content.